Comparing three gels for mild to moderate acne
Part of Skin clinical trials.
This study compares three different gels for treating mild to moderate acne on the face. One gel contains standard acne medication, another adds a steroid, and the third uses a special ingredient from stem cells (called secretome) to see which works best and is safest.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 15 and 40 years old.
- You have mild to moderate acne on your face, and you can count your pimples if asked.
- You have not used any acne treatments on your face in the last 2 weeks (like creams or gels) or taken acne pills in the last 4 weeks.
- You have not taken isotretinoin (like Accutane) in the last 6 months.
- You are not pregnant or breastfeeding.
- You do not have other skin conditions on your face, serious health problems, or recent facial procedures (like laser or deep peels).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new set of skin care products (a cleanser, a combination cream, and a spot cream) to see how well they work and if they are safe for people with mild to moderate acne. If you join, you will use these products as directed, and the researchers will check how your skin improves.
This study compares two prescription gels — metronidazole and clindamycin — to see which works better for moderate acne. You would apply one of the gels to your face and be monitored for improvement.
This trial compares two topical creams, clascoterone and adapalene, to see which works better for mild acne. If you have mild acne and are between 12 and 35, you might be able to join.
This trial studies whether putting antibiotic creams on mild-to-moderate facial acne reduces inflammation. It may help answer whether topical erythromycin or clindamycin can improve acne-related redness and swelling.
This trial tests a new cream called clascoterone for moderate to severe facial acne. It may help reduce pimples and blackheads with fewer side effects than some other treatments.
This trial tests a cream called KR230109 for mild to moderate facial acne. The goal is to see if the cream is safe and helps reduce pimples and blackheads/whiteheads. You will be asked to use the cream as directed and attend study visits.
Hear when a new Acne Vulgaris trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.